Shares of Integer Holdings Corporation (NYSE:ITGR - Get Free Report) have been given an average recommendation of "Buy" by the nine analysts that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $140.25.
ITGR has been the topic of a number of recent analyst reports. Raymond James Financial dropped their price objective on Integer from $150.00 to $143.00 and set an "outperform" rating on the stock in a report on Friday, July 25th. Truist Financial dropped their price objective on Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a report on Friday, July 25th. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and boosted their target price for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Wall Street Zen upgraded Integer from a "hold" rating to a "buy" rating in a research report on Saturday, August 30th. Finally, Wells Fargo & Company decreased their target price on Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a research report on Friday, July 25th.
Read Our Latest Report on ITGR
Integer Trading Up 0.2%
NYSE ITGR traded up $0.22 during trading on Wednesday, hitting $106.82. The stock had a trading volume of 317,647 shares, compared to its average volume of 467,112. The company has a market capitalization of $3.74 billion, a PE ratio of 47.06, a PEG ratio of 0.83 and a beta of 1.03. The company has a quick ratio of 2.18, a current ratio of 3.41 and a debt-to-equity ratio of 0.72. The firm has a 50 day moving average price of $111.61 and a 200 day moving average price of $117.19. Integer has a twelve month low of $104.93 and a twelve month high of $146.36.
Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.02). The company had revenue of $476.00 million during the quarter, compared to analysts' expectations of $464.37 million. Integer had a net margin of 4.61% and a return on equity of 12.27%. The business's quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.30 EPS. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. As a group, equities research analysts forecast that Integer will post 6.01 earnings per share for the current year.
Institutional Investors Weigh In On Integer
Hedge funds have recently bought and sold shares of the business. Russell Investments Group Ltd. lifted its holdings in shares of Integer by 14.7% in the 1st quarter. Russell Investments Group Ltd. now owns 6,749 shares of the medical equipment provider's stock worth $796,000 after purchasing an additional 863 shares during the last quarter. Wealth Enhancement Advisory Services LLC acquired a new position in shares of Integer during the 4th quarter valued at $208,000. Teacher Retirement System of Texas acquired a new position in shares of Integer during the 1st quarter valued at $579,000. Quantbot Technologies LP acquired a new position in shares of Integer in the 1st quarter worth $193,000. Finally, MQS Management LLC acquired a new position in shares of Integer in the 1st quarter worth $272,000. Institutional investors and hedge funds own 99.29% of the company's stock.
About Integer
(
Get Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Further Reading

Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.